Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more) Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Spectral Medical Inc > Operating Capital?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(334)
•••
Comment by hmmmmmmmmon Oct 03, 2022 1:14pm
170 Views
Post# 35001919

RE:RE:Operating Capital?

RE:RE:Operating Capital?These are Spectral's board and management who's business emails were not listed- but others might have better luck finding contacts.

Sam Amory  (Spectral/ Dialco)

Jun Hayakawa  (Toray)

William Stevens  (GS Investment)

Jan D' Alvise   (Acasti Pharma)

Anthony Bihl    anthony.bihl@bioventususglobal.com  -did go through for me

Also here is Spectral's  main phone: 1 888 426- 4264
And investor relations:  1 416 962- 3300


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities